Gut microbiome study in blood cancer and HLH
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how the bacteria in your gut (microbiome) may be linked to blood cancers and HLH. It aims to find new ways to understand and possibly treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a blood cancer or a confirmed diagnosis of HLH (a severe immune condition).
- You must be between 16 and 100 years old.
- You cannot have HIV, hepatitis B, or hepatitis C.
- You cannot have an active contagious illness like COVID-19 or monkeypox.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for a DNA marker in people with HLH caused by lymphoma. It may help doctors better confirm the cause of HLH and guide treatment decisions.
This study collects samples and health information from people with certain blood cancers to learn more about the disease and find markers that may help guide future treatments. You will not receive a treatment from this study, but you may help advance research.
This study looks at gut health in children with certain cancers. It may help researchers understand how to better support children during treatment.
This study looks at specific immune cells (T cells) in people who have a rare condition called Hemophagocytic Lymphohistiocytosis (HLH) together with an aggressive lymphoma. It aims to better understand how these cells behave, which may lead to improved diagnosis or treatment.
This study looks at how the bacteria in your gut change during cancer treatment (and during some blood stem cell transplants). It may help researchers understand why some people respond differently and guide better future treatment.
This study is for people with hemophagocytic lymphohistiocytosis (HLH), a condition where the immune system becomes overactive. Researchers want to collect medical data and blood samples to better understand HLH and find better ways to diagnose and treat it.
Hear when a new Haemophagocytic Lymphohistiocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.